Hydrochloric Acid

Hydrochloric Acid

SCHEMBL3830232

C=CC(=O)OC(C)C(N)(CC)CC.Cl

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TSHR P16473 8/20 0.40
THRB P10828 2/20 0.37
HPGD P15428 1/20 0.35
ALDH1A1 P00352 5/20 0.32
TP53 P04637 3/20 0.32
HIF1A Q16665 3/20 0.32
CYP3A4 P08684 2/20 0.32
MAPK1 P28482 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5672879 0.98 TSHR (0.41) TSHRTHRBHPGDALDH1A1TP53
SCHEMBL10483612 0.95 TSHR (0.39) TSHRTHRBHPGDALDH1A1TP53
Methylsulfanylmethane SCHEMBL10483608 0.93 TSHR (0.38) TSHRTHRBHPGDALDH1A1TP53
Hydrochloric Acid SCHEMBL14335997 0.89 TSHR (0.33) TSHRTHRB
SCHEMBL7797605 0.88 TSHR (0.34) TSHRTHRBHPGD
Hydrochloric Acid SCHEMBL717767 0.82 THRB (0.37) TSHRTHRBHPGDALDH1A1TP53
Hydrochloric Acid SCHEMBL717362 0.79 TSHR (0.39) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL10787047 0.79 TSHR (0.42) TSHRTHRBHPGDALDH1A1TP53
Bromide SCHEMBL28769243 0.79 THRB (0.37) TSHRTHRBHPGDALDH1A1TP53
SCHEMBL23494150 0.78 TSHR (0.42) TSHRTHRBHPGDALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2720668-B1 COSMETIC USE OF A FLOCCULANT POLYMER AS ANTIPERSPIRANT OREAL (FR) 2020-05-06 EP claimed
US-20070248551-A1 Use as an Antiperspirant Agent of a Flocculating Water-Soluble Polymer; Cosmetic Process for Treating Perspiration L'OREAL S.A. (FR) 2007-10-25 US claimed
EP-1761241-A1 USE AS AN ANTIPERSPIRANT AGENT OF A FLOCCULATING WATER-SOLUBLE POLYMER; COSMETIC PROCESS FOR TREATING PERSPIRATION l'Oreal SA (FR) 2007-03-14 EP claimed
WO-2005120448-A1 USE AS AN ANTIPERSPIRANT AGENT OF A FLOCCULATING WATER-SOLUBLE POLYMER; COSMETIC PROCESS FOR TREATING PERSPIRATION L'OREAL (FR) 2005-12-22 WO claimed
US-5952394-A A SYNERGISTIC ANTIDEPOSIT AGENT MIXTURE COMPRISING A PARTIALLY HYDROLYZED POLYVINYL ALCOHOL, A HIGH MOLECULAR WEIGHT GELATIN AND A CATIONIC POLYMER BETZDEARBORN INC. (US) 1999-09-14 US claimed
EP-0900299-A1 COMPOSITIONS AND METHODS FOR INHIBITING DEPOSITS IN PULP AND PAPERMAKING SYSTEMS BetzDearborn Inc (US) 1999-03-10 EP claimed
EP-0900299-A4 1999-03-10 EP claimed
US-5723021-A POLYVINYL ALCOHOL, GELATIN AND CATIONIC POLYMER BETZDEARBORN INC. (US) 1998-03-03 US claimed
WO-1997044519-A1 COMPOSITIONS AND METHODS FOR INHIBITING DEPOSITS IN PULP AND PAPERMAKING SYSTEMS BETZDEARBORN INC. (US) 1997-11-27 WO claimed
CN-115298110-A Cover tape for packaging electronic component and package 大日本印刷株式会社 2022-11-04 CN disclosed
CN-114349901-A Preparation method of flocculant 常州市振邦化工制造有限公司 2022-04-15 CN disclosed
EP-2720668-B1 COSMETIC USE OF A FLOCCULANT POLYMER AS ANTIPERSPIRANT OREAL (FR) 2020-05-06 EP disclosed
EP-1627107-B1 METHOD FOR CONTROLLING PITCH AND STICKIES DEPOSITION HERCULES INC (US) 2009-09-16 EP disclosed
US-20070248551-A1 Use as an Antiperspirant Agent of a Flocculating Water-Soluble Polymer; Cosmetic Process for Treating Perspiration L'OREAL S.A. (FR) 2007-10-25 US disclosed
US-5549832-A PRECIPITATION OF METALS IN WITH ALKALINE COOLANT WITH SODIUM DIALKYLDITHIOCARBAMATE, BASIFICATION FOR COAGULATION, FILTRATION AND CLEANING CENTURY MANUFACTURING COMPANY (US) 1996-08-27 US disclosed
US-5169540-A Treating an aqueous system to separate suspended material BETZ LABORATORIES, INC. (US) 1992-12-08 US disclosed
US-5100951-A Stable blends of cationic water-in-oil emulsion polymers and cationic aqueous solution polymers BETZ LABORATORIES, INC. (US) 1992-03-31 US disclosed
EP-0083984-B1 PREPARATION OF STABLE AQUEOUS DISPERSIONS OF POLYOLEFIN FIBRES HERCULES INCORPORATED (US) 1986-04-30 EP disclosed
US-4404314-A CATIONIC COPOLYMER OF ACRYLAMIDE AND ACRYLATE HERCULES INCORPORATED (US) 1983-09-13 US disclosed
EP-0083984-A1 Preparation of stable aqueous dispersions of polyolefin fibres HERCULES INCORPORATED (US) 1983-07-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070248551-A1 Use as an Antiperspirant Agent of a Flocculating Water-Soluble Polymer; Cosmetic Process for Treating Perspiration CUTA, TYR, PRKDC TSHR 1046/4885THRB 3027/4885HPGD 3541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.